Literature DB >> 24734974

Orthodontic treatment of a patient with hypoglossia.

Takuya Ogawa, Chiemi Sato, Naomi Kawakubo, Keiji Moriyama.   

Abstract

OBJECTIVE: The aim of this case study was to provide a detailed report of the orthodontic approach used in treating a Japanese patient with congenital hypoglossia. PATIENT: The patient was a 6-year-old girl with hypoglossia, micrognathia, congenital absence of three incisors, and a telescopic occlusion accompanied by an extremely narrow lower arch. She had no limb anomalies, and her speech was normal.
RESULTS: Bite opening and mandibular widening from the early mixed dentition dramatically improved the extremely constricted mandible and telescopic occlusion. Cephalometric tracings taken from the beginning to the end of active treatment revealed substantial forward and downward growth in the mandible over time, which may have contributed to correction of the intermaxillary relationship.
CONCLUSIONS: Treatment of telescopic occlusion by bite opening and mandibular widening from the early mixed dentition may be effective in facilitating mandibular growth acceleration. An acceptable intermaxillary occlusal relationship and improvement of profile were achieved by an orthodontic approach in this case.

Entities:  

Keywords:  hypoglossia; micrognathia; orthodontic treatment; telescopic occlusion

Mesh:

Year:  2015        PMID: 24734974     DOI: 10.1597/13-061

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  2 in total

1.  Type IA Oromandibular-Limb Hypogenesis Syndrome: A Case Report and A Case Update.

Authors:  Celine Richard; Amy Manning; Gregory Peason; Scott E Hickey; Andrew R Scott; Jonathan Grischkan
Journal:  Cureus       Date:  2022-05-01

2.  Nonsurgical orthodontic treatment of a hypodivergent adult patient with bilateral posterior scissors bite and excessive overjet.

Authors:  Masahiro Nakamura; Noriaki Kawanabe; Rie Adachi; Takashi Yamashiro; Hiroshi Kamioka
Journal:  Angle Orthod       Date:  2018-08-06       Impact factor: 2.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.